Even though it is unclear how SH3BGRL is directly involved in heart failure, SH3BGRL has evolved into a biomarker for identifying cardiotoxic agents and for diagnosing heart diseases (Narain et al., 2014). This evidence concerns the gene SH3BGRL and heart failure.